#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16314	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2595	775.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1653	1653	C	1071	C,T	1069,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27190	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3986	848.7	0	.	n	.	0	T695C	SNP	695	695	T	1307	1307	C	994	C,T,A,G	987,4,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27190	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3986	848.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1949	1949	A	1097	A,C	1095,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27190	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3986	848.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2583	2583	C	1023	C,T	1021,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27190	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3986	848.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2657	2657	A	956	A,G,C,T	952,1,2,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27190	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3986	848.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3209	3209	C	955	C,G	953,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2374	folP	855	855	100.0	folP.l15.c4.ctg.1	1936	152.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1213	1215	AGC	253;253;255	A,C;G,C,T;C	252,1;251,1,1;255	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5808	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3846	188.2	1	SNP	p	S91F	1	.	.	271	273	TTC	863	865	TTC	228;230;230	T,C;T;C	226,2;230;230	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5808	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3846	188.2	1	SNP	p	D95G	1	.	.	283	285	GGC	875	877	GGC	239;239;238	G;G;C	239;239;238	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5808	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3846	188.2	1	SNP	p	G95N	0	.	.	283	285	GGC	875	877	GGC	239;239;238	G;G;C	239;239;238	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	2176	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1767	153.4	1	SNP	p	G45D	0	.	.	133	135	GGC	669	671	GGC	239;240;243	G;G,C;C	239;239,1;243	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1164	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1373	105.1	0	.	n	.	0	A197.	DEL	197	197	A	770	770	A	234	A	234	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5460	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3268	207.8	1	SNP	p	D86N	0	.	.	256	258	GAC	726	728	GAC	268;268;263	G,T;A,G,C;C	267,1;266,1,1;263	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5460	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3268	207.8	1	SNP	p	R87I	0	.	.	259	261	CGT	729	731	CGT	265;263;262	C,A;G;T,C	264,1;263;261,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5460	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3268	207.8	1	SNP	p	R87W	0	.	.	259	261	CGT	729	731	CGT	265;263;262	C,A;G;T,C	264,1;263;261,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5460	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3268	207.8	1	SNP	p	S87R	1	.	.	259	261	CGT	729	731	CGT	265;263;262	C,A;G;T,C	264,1;263;261,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5460	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3268	207.8	1	SNP	p	S88P	0	.	.	262	264	TCC	732	734	TCC	263;268;264	T;C,T;C	263;267,1;264	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4652	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3108	186.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1792	1794	GGC	250;250;246	G,T,A;G;C,T	248,1,1;250;245,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4430	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2884	191.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1455	1457	GCA	267;265;267	G,T,A;C,T,G;A,T	265,1,1;263,1,1;266,1	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4430	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2884	191.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1458	1460	ATC	269;268;270	A,C;T;C	268,1;268;270	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4430	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2884	191.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1470	1472	GTG	267;269;265	G;T;G	267;269;265	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4430	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2884	191.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1470	1472	GTG	267;269;265	G;T;G	267;269;265	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4430	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2884	191.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1974	1976	ACC	261;260;257	A,G;C,T;C	260,1;259,1;257	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4430	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2884	191.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2028	2030	GCG	263;260;255	G;C,T,G;G,A,T	263;258,1,1;253,1,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4430	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2884	191.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2028	2030	GCG	263;260;255	G;C,T,G;G,A,T	263;258,1,1;253,1,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4430	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2884	191.5	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2151	2153	AGC	217;213;214	A,G;G;C,A	216,1;213;213,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4430	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2884	191.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2160	2162	GGC	228;232;233	G;G;C	228;232;232	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4430	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2884	191.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2178	2180	CCG	243;246;248	C,T;C;G	242,1;245;248	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5856	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3451	211.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1826	1828	CCG	247;250;249	C;C;G,T	247;250;248,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2676	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2324	143.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	826	826	C	183	C	183	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	525	26.6	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	28;31;36	T;T;A	28;31;36	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	525	26.6	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	70;70;70	C;A;T	70;70;70	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	525	26.6	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	70;70;70	A,G;G;T	69,1;70;70	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	525	26.6	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	70;70;70	T;A;C,G	70;70;69,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	525	26.6	0	.	p	.	0	R307A	NONSYN	919	921	AGA	161	163	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	525	26.6	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	525	26.6	0	.	p	.	0	E312D	NONSYN	934	936	GAA	176	178	GAC	2;2;2	G;A;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	525	26.6	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	2;3;3	A;T;C	2;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	525	26.6	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	3;3;3	T;C;G	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	525	26.6	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	3;3;3	G;C;C	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	525	26.6	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	3;3;3	A;G;C	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	525	26.6	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	3;3;3	G;C;C	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	314	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	525	26.6	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	3;3;3	G;T;T	3;3;3	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3104	porB1b	1041	1041	97.41	porB1b.l15.c30.ctg.1	1763	217.0	0	.	p	.	0	V75I	NONSYN	223	225	GTT	617	619	ATT	289;289;289	A;T;T	289;289;289	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3104	porB1b	1041	1041	97.41	porB1b.l15.c30.ctg.1	1763	217.0	0	.	p	.	0	T89S	NONSYN	265	267	ACC	659	661	AGC	293;291;290	A;G,A;C	293;290,1;290	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3104	porB1b	1041	1041	97.41	porB1b.l15.c30.ctg.1	1763	217.0	0	.	p	.	0	V98I	NONSYN	292	294	GTC	686	688	ATC	275;273;275	A,G;T;C	274,1;273;274	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3104	porB1b	1041	1041	97.41	porB1b.l15.c30.ctg.1	1763	217.0	0	.	p	.	0	.	MULTIPLE	358	359	AA	751	752	CG	247;247	C;G	247;247	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3104	porB1b	1041	1041	97.41	porB1b.l15.c30.ctg.1	1763	217.0	0	.	p	.	0	.	MULTIPLE	361	362	GA	754	756	CAG	245;244;245	C,G;A;G	244,1;244;245	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3104	porB1b	1041	1041	97.41	porB1b.l15.c30.ctg.1	1763	217.0	0	.	p	.	0	N122K	NONSYN	364	366	AAC	758	760	AAA	243;242;243	A;A;A	243;242;243	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3104	porB1b	1041	1041	97.41	porB1b.l15.c30.ctg.1	1763	217.0	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	785	787	TAT	228;225;230	T;A;T	228;225;230	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3104	porB1b	1041	1041	97.41	porB1b.l15.c30.ctg.1	1763	217.0	0	.	p	.	0	N134E	NONSYN	400	402	AAT	794	796	GAG	225;224;223	G;A;G	225;224;223	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3104	porB1b	1041	1041	97.41	porB1b.l15.c30.ctg.1	1763	217.0	0	.	p	.	0	V135L	NONSYN	403	405	GTG	797	799	CTT	227;229;229	C,T,A;T,G;T	225,1,1;228,1;229	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3104	porB1b	1041	1041	97.41	porB1b.l15.c30.ctg.1	1763	217.0	0	.	p	.	0	G140K	NONSYN	418	420	GGA	812	814	AAA	237;235;232	A;A;A	237;235;232	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3104	porB1b	1041	1041	97.41	porB1b.l15.c30.ctg.1	1763	217.0	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	821	823	GAA	239;240;240	G,A;A;A	238,1;240;240	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3104	porB1b	1041	1041	97.41	porB1b.l15.c30.ctg.1	1763	217.0	0	.	p	.	0	A213S	NONSYN	637	639	GCA	1031	1033	TCA	283;281;282	T;C,G,A;A	282;278,1,1;282	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3104	porB1b	1041	1041	97.41	porB1b.l15.c30.ctg.1	1763	217.0	0	.	p	.	0	Y255W	NONSYN	763	765	TAC	1157	1159	TGG	301;300;297	T,G;G;G	300,1;300;297	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3104	porB1b	1041	1041	97.41	porB1b.l15.c30.ctg.1	1763	217.0	0	.	p	.	0	E326A	NONSYN	976	978	GAA	1370	1372	GCA	256;258;259	G;C;A	256;258;259	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3104	porB1b	1041	1041	97.41	porB1b.l15.c30.ctg.1	1763	217.0	1	SNP	p	G120K	1	.	.	358	360	AAG	751	753	CGG	247;247;246	C;G;G	247;247;246	porB1b.WHO_X_02194c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3104	porB1b	1041	1041	97.41	porB1b.l15.c30.ctg.1	1763	217.0	1	SNP	p	A121D	1	.	.	361	363	GAC	754	757	CGC	245;245;248	C,G;G;C,A	244,1;245;247,1	porB1b.WHO_X_02194c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	3104	porB1b	1041	1041	97.41	porB1b.l15.c30.ctg.1	1763	217.0	1	SNP	p	D121N	0	.	.	361	363	GAC	754	757	CGC	245;245;248	C,G;G;C,A	244,1;245;247,1	porB1b.WHO_X_02194c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10438	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5357	242.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1500	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1552	120.6	1	SNP	p	V57M	1	.	.	169	171	ATG	725	727	ATG	268;267;264	A;T,G;G,T	268;266,1;263,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
